Cargando…
AB0 Blood Group and Ovarian Cancer Survival
Background: Epithelial ovarian cancer is the most lethal gynecological malignancy because is usually diagnosed at advanced stage. New prognostic factors have been investigated but these biomarkers do not have a strong direct relationship with survival. Several studies investigated the association be...
Autores principales: | Mandato, Vincenzo Dario, Torricelli, Federica, Mastrofilippo, Valentina, Ciarlini, Gino, Pirillo, Debora, Annunziata, Gianluca, Casali, Bruno, Abrate, Martino, Sala, Giovanni Battista La, Aguzzoli, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548162/ https://www.ncbi.nlm.nih.gov/pubmed/31205554 http://dx.doi.org/10.7150/jca.29272 |
Ejemplares similares
-
Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies
por: Mandato, Vincenzo Dario, et al.
Publicado: (2017) -
Should Endometrial Cancer Treatment Be Centralized?
por: Mandato, Vincenzo Dario, et al.
Publicado: (2022) -
An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear
por: Mandato, Vincenzo Dario, et al.
Publicado: (2021) -
The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review
por: Generali, Matteo, et al.
Publicado: (2023) -
HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study
por: Mandato, Vincenzo Dario, et al.
Publicado: (2015)